We are live on ! Find out more
DERM icon

Journey Medical
DERM

13 hedge funds and large institutions have $6.58M invested in Journey Medical in 2022 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.87% more ownership

Funds ownership: 14.53% → 15.39% (+0.87%)

7% less funds holding

Funds holding: 14 → 13 (-1)

17% less capital invested

Capital invested by funds: $7.94M → $6.58M (-$1.36M)

20% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 5

25% less repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 4

Holders
13
Holders Change
-1
Holders Change %
-7.14%
% of All Funds
0.22%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
3
Reduced
4
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
OM
Opaleye Management
Massachusetts
+$707K
2
PCM
Perkins Capital Management
Minnesota
+$112K
3
BRWM
B. Riley Wealth Management
Tennessee
+$59.3K
4
Creative Planning
Creative Planning
Kansas
+$46.5K
5
Vanguard Group
Vanguard Group
Pennsylvania
+$41.3K

Top Sellers

Rank Fund Capital Flow
1
MAG
Millrace Asset Group
Pennsylvania
-$392K
2
Millennium Management
Millennium Management
New York
-$103K
3
Renaissance Technologies
Renaissance Technologies
New York
-$75K
4
Goldman Sachs
Goldman Sachs
New York
-$53K
5
Neuberger Berman Group
Neuberger Berman Group
New York
-$1.98K
Name Holding Trade Value Shares
Change 		Change in
Stake
BRF
1
B. Riley Financial
California
$3.23M – – –
OM
2
Opaleye Management
Massachusetts
$919K +$707K +178,733 +267%
PCM
3
Perkins Capital Management
Minnesota
$823K +$112K +28,300 +15%
Neuberger Berman Group
4
Neuberger Berman Group
New York
$737K -$1.98K -500 -0.3%
AFG
5
American Financial Group
Ohio
$673K – – –
BRWM
6
B. Riley Wealth Management
Tennessee
$56.1K +$59.3K +15,000 New
Creative Planning
7
Creative Planning
Kansas
$44K +$46.5K +11,764 New
Vanguard Group
8
Vanguard Group
Pennsylvania
$39K +$41.3K +10,435 New
BlackRock
9
BlackRock
New York
$32K -$558 -141 -2%
UBS Group
10
UBS Group
Switzerland
$10K -$1.92K -485 -15%
TRCT
11
Tower Research Capital (TRC)
New York
$8K -$471 -119 -6%
EIM
12
Essex Investment Management
Massachusetts
$5K +$5.54K +1,400 New
MAG
13
Millrace Asset Group
Pennsylvania
– -$392K -81,070 Closed
Millennium Management
14
Millennium Management
New York
– -$103K -21,449 Closed
Renaissance Technologies
15
Renaissance Technologies
New York
– -$75K -15,600 Closed
Goldman Sachs
16
Goldman Sachs
New York
– -$53K -10,926 Closed
PMFA
17
Plante Moran Financial Advisors
Michigan
– -$1K -200 Closed
Wells Fargo
18
Wells Fargo
California
– +$16 +4 +16%

DERM Hedge Fund Activity: Q2 2022 in Review

13 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Journey Medical (DERM) for Q2 2022, worth a combined $6.58M — down 17% from $7.94M a quarter earlier.

Sellers outnumbered buyers: 5 funds closed out of DERM and 4 opened new positions — a net loss of 1 holder — while 4 trimmed existing stakes and 3 added.

The largest buyer was Opaleye Management, adding an estimated $707K. The largest seller was Millrace Asset Group, exiting entirely with an estimated $392K sold.

  • 13 institutional investors held Journey Medical (DERM) as of Q2 2022, down from 14 in Q1 2022.
  • Funds reported $6.58M of Journey Medical stock for Q2 2022, down 17% quarter-over-quarter.
  • 4 funds opened new Journey Medical positions in Q2 2022 and 5 closed out, a net change of -1 holder.
  • The largest Journey Medical buyer in Q2 2022 was Opaleye Management, an estimated $707K added.
  • The largest Journey Medical seller in Q2 2022 was Millrace Asset Group, an estimated $392K sold.

Based on aggregated 13F filings for Q2 2022.